An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint

NCT06485843 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis
Osteo Arthritis Knee

Interventions

DRUG: OA-SYS

Sponsor

Ageless Biotech, Inc.